CRINETICS PHARMACEUTICALS

Serial Number 87875067
Registration 6603347
700

Registration Progress

Application Filed
Apr 12, 2018
Under Examination
Nov 13, 2018
Approved for Publication
Sep 18, 2018
Published for Opposition
Sep 18, 2018
Registered
Dec 28, 2021

Trademark Image

CRINETICS PHARMACEUTICALS

Basic Information

Serial Number
87875067
Registration Number
6603347
Filing Date
April 12, 2018
Registration Date
December 28, 2021
Published for Opposition
September 18, 2018
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Dec 28, 2021
Registration
Registered
Classes
042

Rights Holder

Crinetics Pharmaceuticals, Inc.

03
Address
6055 Lusk Blvd.
San Diego, CA 92121

Ownership History

Crinetics Pharmaceuticals, Inc.

Original Applicant
03
San Diego, CA

Crinetics Pharmaceuticals, Inc.

Owner at Publication
03
San Diego, CA

Crinetics Pharmaceuticals, Inc.

Original Registrant
03
San Diego, CA

Legal Representation

Attorney
Danny M. Awdeh

USPTO Deadlines

Next Deadline
877 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-12-28)
Due Date
December 28, 2027
Grace Period Ends
June 28, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

48 events
Date Code Type Description Documents
Feb 28, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Feb 28, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Feb 28, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Feb 28, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Feb 28, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Dec 28, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Nov 20, 2021 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Nov 19, 2021 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Nov 2, 2021 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Oct 29, 2021 IUAF S USE AMENDMENT FILED Loading...
Oct 29, 2021 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
May 8, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 7, 2021 EX5G S SOU EXTENSION 5 GRANTED Loading...
May 7, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Apr 29, 2021 EXT5 S SOU EXTENSION 5 FILED Loading...
Apr 29, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 30, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 28, 2020 EX4G S SOU EXTENSION 4 GRANTED Loading...
Oct 28, 2020 EXT4 S SOU EXTENSION 4 FILED Loading...
Oct 28, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 28, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 24, 2020 EX3G S SOU EXTENSION 3 GRANTED Loading...
Apr 24, 2020 EXT3 S SOU EXTENSION 3 FILED Loading...
Apr 24, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 23, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 21, 2019 EX2G S SOU EXTENSION 2 GRANTED Loading...
Oct 21, 2019 EXT2 S SOU EXTENSION 2 FILED Loading...
Oct 21, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 19, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 17, 2019 EX1G S SOU EXTENSION 1 GRANTED Loading...
Apr 17, 2019 EXT1 S SOU EXTENSION 1 FILED Loading...
Apr 17, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 17, 2019 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Apr 17, 2019 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Nov 13, 2018 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 18, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 18, 2018 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 29, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 16, 2018 ALIE A ASSIGNED TO LIE Loading...
Aug 6, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 6, 2018 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Aug 6, 2018 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Aug 6, 2018 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Aug 6, 2018 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jul 31, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 24, 2018 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Apr 21, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 16, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Medical and pharmaceutical research services; pharmaceutical research and development; research and development in pharmacology for the purpose of modulating neuropeptides and G-protein coupled receptors (GPCRs); medical research for use in oncology; medical research in the field of pharmacology for treating endocrine disorders and endocrine-related cancers; pharmaceutical research for the purpose of targeting neuropeptide receptors; pharmaceutical research for treating acromegaly, neuroendocrine tumors, Cushing's Disease, hyperinsulinism, and chronic pain; medical research for the treatment or prevention of dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; providing medical and scientific research information in the field of pharmaceuticals; medical and scientific research, namely, conducting clinical trials for others
First Use Anywhere: May 12, 2021
First Use in Commerce: May 12, 2021

Additional Information

Design Mark
The mark consists of the word "CRINETICS" above the word "PHARMACEUTICALS" with a dot and line spirograph design in the shape of a half circle starting above the letter "I" in "CRINETICS" and wrapping around the first letter "C" in "CRINETICS".
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMACEUTICALS"